In other countries
The same active substances on other registers, the same brand first.
- VegzelmaBrazil · Celltrion Healthcare Distribuicao de Produtos Farmaceuticos Dos Brasil LtdaSame brand
- Vegzelma 25 MG/ML Concentrado Para Solucion Para PerfusionSpain · 100 mg · concentrado para solución para perfusión · Celltrion Healthcare Hungary Kft.Same brand
- VegzelmaEuropean Union · Celltrion Healthcare Hungary Kft.Same brand
- VegzelmaCroatiaSame brand
- VegzelmaItaly · Concentrato per soluzione per infusione · Celltrion Healthcare Hungary KFTSame brand
- Vegzelma 25 mg/ml concentraat voor oplossing voor infusieNetherlands · Concentraat voor oplossing voor infusie · Celltrion Healthcare Hungary Kft.Same brand
- Vegzelma 25 mg/ml concentraat voor oplossing voor infusieNetherlands · Concentraat voor oplossing voor infusie · Celltrion Healthcare Hungary Kft.Same brand
- VegzelmaNew Zealand · Inj 25 mg per ml, 4 ml vialSame brand
- VegzelmaNew Zealand · Inj 25 mg per ml, 16 ml vialSame brand
- Vegzelma Concentrate for Solution for Infusion 25 MG/MLSingapore · 25 mg/ml · infusion, solution concentrate · Celltrion Healthcare Singapore Private LimitedSame brand
- VegzelmaUnited States · 100MG/4ML, 400MG/16ML · injectable · CelltrionSame brand
- Alymsys®Serbia · 400mg/16mL · koncentrat za rastvor za infuziju · Zentiva Pharma D.O.O.Same strength and form
- Avastin®Serbia · 400mg/16mL · koncentrat za rastvor za infuziju · Roche DOO BeogradSame strength and form
- Avastin®Serbia · 400mg/16mL · koncentrat za rastvor za infuziju · Roche DOO BeogradSame strength and form
- LumiereArgentina · 5 MG/ 0,2 ML · solución inyectable · Laboratorio Elea - Phoenix S.A.Same substance
- AbevmyBrazil · Biocon Biologics do Brasil LtdaSame substance
- AvastinBrazil · Produtos Roche Químicos e Farmacêuticos S.A.Same substance
- Abevmy 25 MG/ML Concentrado Para Solucion Para PerfusionSpain · 25 mg/ml · concentrado para solución para perfusión · Biosimilar Collaborations Ireland LimitedSame substance
- Alymsys 25 MG/ML Concentrado Para Solucion Para PerfusionSpain · 25 mg/ml · concentrado para solución para perfusión · Mabxience Research S.L.Same substance
- AbevmyEuropean Union · Biosimilar Collaborations Ireland LimitedSame substance
- AlymsysEuropean Union · Mabxience Research SLSame substance
- AbevmyCroatiaSame substance
- AlymsysCroatiaSame substance
- AbevmyItaly · Concentrato per soluzione per infusione · Biosimilar Collaborations Ireland LimitedSame substance
- AlymsysItaly · Concentrato per soluzione per infusione · Mabxience Research SLSame substance
- Abevmy 25 mg/ml concentraat voor oplossing voor infusieNetherlands · Concentraat voor oplossing voor infusie · Biosimilar Collaborations Ireland LimitedSame substance
- AnyNew Zealand · Inj 25 mg per ml, 16 ml vialSame substance
- AVASTIN 25mg/mlRomania · 25mg/ml · conc. pt. sol. perf. · Roche Registration GMBHSame substance
- MVASI 25mg/mlRomania · 25mg/ml · conc. pt. sol. perf. · Amgen Technology (Ireland) UcSame substance
- AVASTIN 100 solution for infusionSaudi Arabia · Roche DiagnosticsSame substance
- AVASTIN 400 solution for infusionSaudi Arabia · Roche DiagnosticsSame substance
- MvasiSaudi Arabia · Amgen Europe B.V.Same substance
- AVAMAB Concentrate for Solution for Infusion 400mg/16mLSingapore · 400mg/16ml · infusion, solution concentrate · Innogene Kalbiotech Pte. LTD.Same substance
- Abevmy™ Concentrate for Solution for Infusion 25MG/MLSingapore · 25 mg/ml · injection, solution, concentrate · Cedar Pharmaceuticals Pte. LTD.Same substance
- AbevmyTaiwan · 注射液劑 · 台灣生資科技股份有限公司Same substance
- Alymsys concentrate for solution for InfusionTaiwan · 注射劑 · 美時化學製藥股份有限公司Same substance
- AlymsysUnited States · 100MG/4ML(25MG/ML, 400MG/16ML(25MG/ML · injectable · Amneal Pharms LLCSame substance
- JobevneUnited States · 100MG/4ML, 400MG/16ML · injectable · Biocon Biologics INCSame substance
Documents
The official texts, at the regulator.
Sources and licences
Compiled by Prognia from the public register below; the register’s text is the official one.
Health Canada, Canada
Health Canada, Drug Product Database, drugproduct API, entire response observed 2026-10-10T15:12:07.336870+00:00; native facts projected by Prognia.
Licence: Open Government Licence Canada · Added 13 Oct 2026
Report an error or request removalCorrections from the holder or the register are welcome.
Prognia shows this product information for reference and learning. It is not treatment advice and can lag behind the official text. Always check the current product information and local protocols before prescribing.
At a glance
- Active substance
- Bevacizumab
- Strength
- 400 MG / 16 ML
- Dosage form
- Solution
- Route
- Intravenous
- Register
- Canada (Health Canada)
- Status
- Marketed
- Authorised
- 1 May 2023
- Registration
- DIN 02534185
- Marketing authorisation holder
- Celltrion INC.
- ATC code
- L01FG01
- Supply
- PRESCRIPTION, SCHEDULE D